Composition
- Active ingredients
- GOLIMUMAB-SLDI 50MG/4ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761452.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Immgolis Intri
- Active substance
- golimumab-sldi
- Route
- Solution
- Dosage form
- Injection
- Applicant
- Accord Biopharma Inc.
- Status
- Prescription
- FDA approval
- 15 May 2026
- Application
- BLA761452-003